A. Raben

发表

Combined 3‐dimensional conformal radiotherapy and transperineal Pd‐103 permanent implantation for patients with intermediate and unfavorable risk prostate cancer

M. Zelefsky, A. Singh, A. Raben, 2000, International journal of cancer.

Comparison of outcome and morbidity of 3-dimensional conformal radiotherapy versus transperineal permanent I-125 implantation for early stage prostatic cancer

K. Wallner, M. Zelefsky, A. Raben, 1998 .

Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer.

K. Wallner, M. Zelefsky, A. Raben, 2000, International journal of radiation oncology, biology, physics.

Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation.

G J Kutcher, C C Ling, S A Leibel, 1999, International journal of radiation oncology, biology, physics.

Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach.

Lei Dong, Lifei Zhang, S. Bhide, 2007, International journal of radiation oncology, biology, physics.

Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer.

J. Dancey, A. Raben, A. Baron, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules

F. Mourtada, A. Raben, A. Dicker, 2018, Cancer growth and metastasis.

Combination of post-operative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: A propensity score analysis.

N. Hockstein, A. Hanlon, A. Raben, 2018, Oral oncology.

Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.

C. Ling, K. Rosenzweig, M. Kris, 2000, Cancer journal.

Biochemical control and toxicity for favorable- and intermediate-risk patients using real-time intraoperative inverse optimization prostate seed implant: Less is more!

A. Hanlon, F. Mourtada, A. Raben, 2017, Brachytherapy.

Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach.

A. Raben, D. Raben, Kyle E. Rusthoven, 2009, International journal of radiation oncology, biology, physics.

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

R. Socher, James Y. Zou, S. Yeung, 2022, npj Digital Medicine.

Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer

R. Spiro, E. Strong, J. Shah, 1996, Head & neck.

Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue

E. Strong, J. Shah, M. Zelefsky, 1998, Head & neck.

Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.

Christopher U. Jones, H. Sandler, J. Efstathiou, 2016, European urology.

The role of radiation therapy in the management of thyroid cancer.

A. Raben, J. Strasser, C. Koprowski, 2008, Surgical oncology clinics of North America.

The Initial Report of Local Control on RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Treated Without Surgery

M. Suntharalingam, A. Raben, A. Dicker, 2014 .

Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: updated results of an institutional clinical management approach.

N. Hockstein, A. Raben, D. Raben, 2015, Oral oncology.

A phase III protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by chemotherapy (CT) with docetaxel and prednisone for localized, high-risk prostate cancer (RTOG 0521).

R. Hannan, J. Purdy, M. Amin, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiation Therapy for Malignant Salivary Gland Tumors

A. Raben, David Gasalberti, 2021 .

Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617

J. Galvin, P. Iyengar, H. Choy, 2015 .

Dosimetric Characterization of an Abscopal Response in a Patient With Oligometastatic Melanoma Undergoing Concurrent Treatment With Pembrolizumab and Stereotactic Body Radiotherapy (SBRT)

F. Mourtada, A. Raben, J. Sims-Mourtada, 2018, Cancer Studies and Molecular Medicine - Open Journal.

Final report of the 70.2 GY and 75.6 GY dose levels of a phase I dose escalation study using three dimensional conformal radiotherapy in the treatment of inoperable lung cancer

C. Ling, K. Rosenzweig, G. Mageras, 1998 .

Sarcoidosis and so-called sarcoid reactions.

A. Raben, 1962, Postgraduate medicine.

Institutional clinical trial accrual volume and survival of patients with head and neck cancer.

Quynh-Thu Le, Qian Wu, Mitchell Machtay, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial.

T. Pisansky, A. Raben, L. Kachnic, 2014, JAMA.

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

K. Harrington, N. Lee, R. Ferris, 2019, Journal of Immunotherapy for Cancer.

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129.

Christopher U. Jones, K. Ang, R. Weber, 2017, International journal of radiation oncology, biology, physics.

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

K. Rosenzweig, V. Rusch, E. Venkatraman, 2001, The Journal of thoracic and cardiovascular surgery.

Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial

M. Suntharalingam, A. Raben, A. Dicker, 2017, JAMA oncology.

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.

R. Hannan, H. Sandler, J. Purdy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.

J. Galvin, P. Iyengar, H. Choy, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Pancreatic Cancer : Current Limitations , Future Possibilities

A. Raben, B. Minsky, 2017 .

Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques.

Jimm Grimm, Dayee Jacob, Abhirup Sarkar, 2008, International journal of radiation oncology, biology, physics.

Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy.

A. Raben, E. Casper, L. Harrison, 1996, International journal of radiation oncology, biology, physics.

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

K. Ang, R. Weber, C. Chung, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.

K. Wallner, C. Ling, M. Zelefsky, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic Cancer

Michael J. Zelefsky, Kent Wallner, C. Clifton Ling, 1999 .

Comparison o f t he 5 -Year O utcome a nd M orbidity of T hree-Dimensiona l C onformal R adiotherapy Versus T ransperineal P ermanent I odine-125 I mplantation for E arly-Stage P rostatic C ancer

K. Wallner, C. Ling, M. Zelefsky, 1999 .

Pathologic features from prostate needle biopsy and prognosis after I-125 brachytherapy.

K. Wallner, A. Raben, A. Grann, 1998, Radiation oncology investigations.

A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesothelioma.

K. Rosenzweig, V. Rusch, M. Zelefsky, 2005, Brachytherapy.

A prospective phase ii trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck

R. Spiro, E. Strong, J. Shah, 1998, Head & neck.

CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933

M. Mehta, H. Rowley, W. Tomé, 2015, Journal of Neuro-Oncology.

Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma.

E. Strong, J. Shah, M. Zelefsky, 1997, International journal of radiation oncology, biology, physics.

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

Christopher U. Jones, H. Sandler, A. Raben, 2017, Advances in radiation oncology.

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer.

M. Kris, V. Rusch, M. Zelefsky, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

R. Socher, James Y. Zou, M. Lungren, 2022, npj Digital Medicine.

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials

M. Suntharalingam, A. Raben, C. Hallemeier, 2023, JAMA network open.

Salvage Low Dose Rate Prostate Brachytherapy: Clinical Outcomes of a Phase II Trial for Local Recurrence after External Beam Radiotherapy (NRG Oncology/xxxx).

D. Beyer, H. Sandler, É. Vigneault, 2021, International journal of radiation oncology, biology, physics.

A method for increased dose conformity and segment reduction for SMLC delivered IMRT treatment of the prostate.

Benjamin Movsas, Eric Horwitz, Alan Pollack, 2003, International journal of radiation oncology, biology, physics.

Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial

D. Yan, H. Sandler, M. Lock, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term results of NRG Oncology/RTOG 0321 a phase II trial of combined high dose rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate.

I. Hsu, G. Gustafson, H. Sandler, 2019, International journal of radiation oncology, biology, physics.

High dose per fraction, short course irradiation for malignant melanoma of the head and neck

M. Zelefsky, A. Raben, L. Harrison, 1993 .

The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.

M. Suntharalingam, A. Raben, A. Dicker, 2014 .

Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.

S. Sim, A. Raben, Hansen Chen, 2004, International journal of radiation oncology, biology, physics.

Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma

A. Garden, J. Mechalakos, P. Harari, 2023, JAMA network open.

Brachytherapy for non-small cell lung cancer and selected neoplasms of the chest.

B. Mychalczak, A. Raben, B. Mychalczak, 1997, Chest.

Dose Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Suppression for Intermediate Risk Prostate Cancer: Outcomes From the NRG Oncology/RTOG 0815 Randomized Trial.

A. Martinez, H. Sandler, M. Lock, 2021, International journal of radiation oncology, biology, physics.

Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.

D. Beyer, C. Catton, H. Sandler, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

21 Long term results of primary radiation therapy for squamous cancer of the base of tongue

E. Strong, J. Shah, M. Zelefsky, 1996 .

Initial comparison of inverse optimization, modified peripheral technique, and geometric optimization as real-time intraoperative computer planning options for permanent seed implantation of the prostate.

Paul J. Koprowski, S. Sim, A. Hanlon, 2007, Brachytherapy.

Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.

A. Raben, D. Raben, Kyle E. Rusthoven, 2009, Brachytherapy.

[Dermatopathic lymphadenopathy].

A. Raben, N. Pokrovskaia, M. A. Reĭzinger, 1973, Klinicheskaia meditsina.

RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.

M. Suntharalingam, A. Raben, A. Dicker, 2014 .

Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach.

A. Raben, D. Raben, Kyle E. Rusthoven, 2009, International journal of radiation oncology, biology, physics.

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

R. Ferris, Q. Le, A. Raben, 2019, Journal of Immunotherapy for Cancer.